Avid Bioservices, Inc. (CDMO)
USD 12.3
(-0.49%)
USD 12.3
(-0.49%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 10.95 Million | -12.88 Million | 9.46 Million | 31.18 Million | 5.82 Million | -11.59 Million |
| Net Income | -140.75 Million | 560 Thousand | 127.67 Million | 11.21 Million | -10.46 Million | -4.21 Million |
| Depreciation & Amortization | 11.1 Million | 7.21 Million | 4.48 Million | 3.45 Million | 3.09 Million | 2.74 Million |
| Deferred income taxes | 113.82 Million | 1.44 Million | -115.08 Million | - | - | - |
| Stock-based compensation | 9.73 Million | 10.97 Million | 7.38 Million | 3.85 Million | 2.49 Million | 1.59 Million |
| Change in working capital | 13.44 Million | -34.26 Million | -16.39 Million | 11.74 Million | 10.69 Million | -10.84 Million |
| Other non-cash items | 15.97 Million | 1.18 Million | 1.41 Million | 916 Thousand | 13 Thousand | -873 Thousand |
| Investing Cash Flow | -31.8 Million | -77.63 Million | -56.41 Million | -9.86 Million | -3.81 Million | 4.54 Million |
| Investments in PPE | -31.8 Million | -77.63 Million | -56.41 Million | -9.86 Million | -3.81 Million | -1.5 Million |
| Acquisitions | - | - | - | - | - | 6.04 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -77.63 Million | -56.41 Million | -9.86 Million | - | 6.04 Million |
| Financing Cash Flow | 20.06 Million | 2.9 Million | 3.19 Million | 112.33 Million | 1.09 Million | -2.86 Million |
| Debt repayment | -18.67 Million | -505 Thousand | -162 Thousand | -93 Thousand | -78 Thousand | -74 Thousand |
| Dividends payments | - | - | - | -4.45 Million | -4.32 Million | -4.32 Million |
| Common Stock Repurchased | - | - | - | -40.49 Million | 187 Thousand | 258 Thousand |
| Common Stock Issuance | 1.39 Million | 3.4 Million | 3.35 Million | 32.14 Million | 1.12 Million | 1.53 Million |
| Other Financing Activities | 1.34 Million | 3.4 Million | 3.19 Million | 125.23 Million | 5.49 Million | 1.53 Million |
| Accounts receivables | -1.1 Million | 2.24 Million | -1.7 Million | -10.23 Million | -1.23 Million | -3.62 Million |
| Accounts payables | 7.13 Million | 964 Thousand | -943 Thousand | -608 Thousand | 802 Thousand | 2.12 Million |
| Inventory | 13.53 Million | -17.84 Million | -14.19 Million | -988 Thousand | -4.32 Million | 1.7 Million |
| Other working capital | -6.11 Million | -19.63 Million | 443 Thousand | 23.57 Million | 15.44 Million | -11.05 Million |
| Cash at beginning of period | 38.54 Million | 126.51 Million | 170.26 Million | 36.61 Million | 33.5 Million | 43.41 Million |
| Cash at end of period | 38.1 Million | 38.89 Million | 126.51 Million | 170.26 Million | 36.61 Million | 33.5 Million |
| Capital Expenditure | -31.8 Million | -77.63 Million | -56.41 Million | -9.86 Million | -3.81 Million | -1.5 Million |
| Effect of forex changes on cash | - | 90.82 Million | - | - | - | - |
| Net cash flow / Change in cash | -436 Thousand | -87.62 Million | -43.74 Million | 133.65 Million | 3.11 Million | -9.91 Million |
| Free Cash Flow | -20.85 Million | -90.52 Million | -46.94 Million | 21.31 Million | 2.01 Million | -13.09 Million |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -140.75 Million | -123.1 Million | -6 Million | -9.5 Million | -2.09 Million | -309 Thousand |
| Depreciation & Amortization | 11.1 Million | 2.85 Million | 2.92 Million | 2.78 Million | 2.64 Million | 1.88 Million |
| Deferred income taxes | 113.82 Million | 117.91 Million | -1.08 Million | -2.37 Million | -599 Thousand | 941 Thousand |
| Stock-based compensation | 9.73 Million | 2.46 Million | 2.45 Million | 2.46 Million | 2.34 Million | 3.55 Million |
| Change in working capital | 13.44 Million | -1.51 Million | 5.22 Million | 12.43 Million | 9.81 Million | -3.58 Million |
| Other non-cash items | 15.97 Million | 902 Thousand | 12.17 Million | 300 Thousand | -12.39 Million | 321 Thousand |
| Investing Cash Flow | -31.8 Million | -5.69 Million | -4.48 Million | -7.32 Million | -14.11 Million | -24.87 Million |
| Investments in PPE | -31.8 Million | -5.69 Million | -4.48 Million | -7.32 Million | -14.11 Million | -24.87 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 20.06 Million | 11.83 Million | 85 Thousand | 7.4 Million | 748 Thousand | 704 Thousand |
| Debt repayment | -18.67 Million | -11.82 Million | -7.11 Million | -132 Thousand | -130 Thousand | -129 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1.39 Million | 14 Thousand | 384 Thousand | 120 Thousand | 878 Thousand | 833 Thousand |
| Other Financing Activities | 1.34 Million | 14 Thousand | 384 Thousand | 7.41 Million | 748 Thousand | 833 Thousand |
| Accounts receivables | -1.1 Million | 1.72 Million | -6.5 Million | 2.83 Million | 2.08 Million | -3.47 Million |
| Accounts payables | 7.13 Million | 3.99 Million | -1.2 Million | -340 Thousand | 4.68 Million | -1.94 Million |
| Inventory | 13.53 Million | 4.19 Million | 4.01 Million | 2.28 Million | 3.04 Million | 1.19 Million |
| Other working capital | -6.11 Million | -11.42 Million | 8.92 Million | 7.66 Million | -9.81 Million | 629 Thousand |
| Cash at beginning of period | 38.54 Million | 30.7 Million | 31.42 Million | 25.24 Million | 38.89 Million | 60.26 Million |
| Cash at end of period | 38.1 Million | 38.1 Million | 30.7 Million | 31.42 Million | 25.24 Million | 38.89 Million |
| Capital Expenditure | -31.8 Million | -5.69 Million | -4.48 Million | -7.32 Million | -14.11 Million | -24.87 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -436 Thousand | 7.39 Million | -716 Thousand | 6.17 Million | -13.64 Million | -21.37 Million |
| Free Cash Flow | -20.85 Million | -4.43 Million | -801 Thousand | -1.22 Million | -14.39 Million | -22.07 Million |
FNMAI
SEAF
000758
0HNC
FMCCL
7202